Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Coeur Commences Drilling at Silver North's Tim Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Announcement
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by POMMERANTZon Jun 27, 2016 5:39pm
322 Views
Post# 25002763

RE:Announcement

RE:AnnouncementIf any investor that feels that the company or any of its officers have violated securities laws by issuing misleading information or did not disclose material facts that resulted in financial losses, I urge you to contact, at no cost to you, 

Robert Willoughby
Investor Relations Manager
POMERANTZ LLP
600 Third Avenue, 20th Floor
Tel. 212.661.1100 ext 9980
rswilloughby@pomlaw.com



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities